159 related articles for article (PubMed ID: 31441342)
1. Comparison of triptorelin acetate vs triptorelin pamoate in the treatment of Central precocious puberty (CPP): a retrospective study.
Lasorella S; Porto R; Iezzi ML; Pistone C; Marseglia GL; Verrotti A; Brambilla I
Gynecol Endocrinol; 2020 Apr; 36(4):338-340. PubMed ID: 31441342
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study.
Luo X; Zhang C; Yang Y; Xu X; Cheng X; Wei H; Wang L; Huang F; Shi X; Cabri P
Adv Ther; 2023 Oct; 40(10):4574-4588. PubMed ID: 37584898
[TBL] [Abstract][Full Text] [Related]
3. Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty.
Yoo E; Kim S; Jung HL; Shim JY; Shim JW; Kim DS; Kwak JH; Kim ES; Yang A
Front Endocrinol (Lausanne); 2023; 14():1134977. PubMed ID: 36875449
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
J Korean Med Sci; 2021 Aug; 36(34):e219. PubMed ID: 34463062
[TBL] [Abstract][Full Text] [Related]
5. Central precocious puberty in girls: Diagnostic study and auxological response to triptorelin treatment.
Durá-Travé T; Ortega Pérez M; Ahmed-Mohamed L; Moreno-González P; Chueca Guindulain MJ; Berrade-Zubiri S
Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(7):410-416. PubMed ID: 30808564
[TBL] [Abstract][Full Text] [Related]
6. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
[TBL] [Abstract][Full Text] [Related]
8. A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.
Zenaty D; Blumberg J; Liyanage N; Jacqz-Aigrain E; Lahlou N; Carel JC;
Horm Res Paediatr; 2016; 86(3):188-195. PubMed ID: 27603324
[TBL] [Abstract][Full Text] [Related]
9. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty.
Seminara S; Nanni L; Generoso M; Mirri S; Leonardi V; Slabadzianiuk T; Vetrano ML; Buongiorno A; Losi S; Galluzzi F
Horm Res Paediatr; 2010; 73(5):386-9. PubMed ID: 20389110
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central precocious puberty with triptorelin 11.25 mg depot formulation.
Martínez-Aguayo A; Hernández MI; Beas F; Iñiguez G; Avila A; Sovino H; Bravo E; Cassorla F
J Pediatr Endocrinol Metab; 2006 Aug; 19(8):963-70. PubMed ID: 16995580
[TBL] [Abstract][Full Text] [Related]
12. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
Klein K; Yang J; Aisenberg J; Wright N; Kaplowitz P; Lahlou N; Linares J; Lundström E; Purcea D; Cassorla F
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1241-1248. PubMed ID: 26887034
[TBL] [Abstract][Full Text] [Related]
14. Central precocious puberty: treatment with triptorelin 11.25 mg.
Chiocca E; Dati E; Baroncelli GI; Cassio A; Wasniewska M; Galluzzi F; Einaudi S; Cappa M; Russo G; Bertelloni S
ScientificWorldJournal; 2012; 2012():583751. PubMed ID: 22645436
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y; Wei H; Zhang JL; Hou L; Luo XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
[TBL] [Abstract][Full Text] [Related]
16. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
Salerno M; Di Maio S; Gasparini N; Mariano A; Macchia V; Tenore A
Horm Res; 1998; 50(4):205-11. PubMed ID: 9838241
[TBL] [Abstract][Full Text] [Related]
17. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
Lanes R; Soros A; Jakubowicz S
J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
[TBL] [Abstract][Full Text] [Related]
18. High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls.
Freire AV; Escobar ME; Gryngarten MG; Arcari AJ; Ballerini MG; Bergadá I; Ropelato MG
Clin Endocrinol (Oxf); 2013 Mar; 78(3):398-404. PubMed ID: 22845185
[TBL] [Abstract][Full Text] [Related]
19. Central Precocious Puberty: Adult Height in Girls Treated with Quarterly or Monthly Gonadotropin-Releasing Hormone Analog Triptorelin.
Bertelloni S; Massart F; Einaudi S; Wasniewska M; Miccoli M; Baroncelli GI
Horm Res Paediatr; 2015; 84(6):396-400. PubMed ID: 26528763
[TBL] [Abstract][Full Text] [Related]
20. Triptorelin stimulated luteinizing hormone concentrations for diagnosing central precocious puberty: study of diagnostic accuracy.
Vukovic R; Milenkovic T; Soldatovic I; Pekic S; Mitrovic K; Todorovic S
Endocrine; 2022 Mar; 75(3):934-941. PubMed ID: 34826116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
